Pharma

Taking stock of the drug industry, from the lab to the medicine chest

2018 Senate McCaskill

Politics

Former pharma hawk McCaskill: Drug pricing system is a ‘stinking stew of a mess’

Pharmalot

European Medicines Agency is advised to take steps to avoid bias concerns over approvals

By Ed Silverman

advertisement

Pharmalot

Pharmalittle: Opioid companies failed to halt suspicious orders; U.K. diabetics are rationing insulin

By Ed Silverman

advertisement

Hires

Pharmalot

Up and down the ladder: The latest comings and goings

By Ed Silverman

Pharmalot

Pharmalittle: Canada throws cold water on U.S. drug importation; was FDA’s ‘smart pill’ approval smart?

By Elizabeth Cooney

FDA Campus

Pharmalot

Was it really a smart move for the FDA to approve a ‘smart pill’ for treating schizophrenia?

By Ed Silverman

Pharmalot

Pharmalittle: Women make ‘little progress’ in key pharma roles; FDA approves a Merck antibiotic

By Ed Silverman

advertisement

Pharmalot

Novartis sets aside $700 million to settle long-running bribery allegations in the U.S.

By Ed Silverman

advertisement

Pharmalot

An Indian drug maker sent records to its scrapyard before the FDA visited

By Ed Silverman

Pharmalot

Pharmalittle: Data show pharma saturated U.S. with opioids; Swiss extradite Chinese researcher

By Ed Silverman

Pharmalot

Pharmalittle: Pharma keeps winning in Washington; J&J faces test as Oklahoma opioid trial wraps up

By Ed Silverman

Pharma wins in Washington illustration

Special Report

How pharma, under attack from all sides, keeps winning in Washington

By Nicholas Florko and Lev Facher

FDA room

Pharmalot

The FDA disagrees with its own expert panels how often?

By Ed Silverman

Pharmalot

Pharmalittle: Glaxo is set to hire a new chairman; Gilead tries to bulk up with new deal

By Ed Silverman

Drug Prices Lobbying

Pharmalot

Lawmakers urge Trump administration to alter trade deal or Americans will pay more for drugs

By Ed Silverman

Hires

Pharmalot

Up and down the ladder: The latest comings and goings

By Ed Silverman

Pharmalot

Pharmalittle: Sanders will travel to Canada to buy cheaper insulin; another Alzheimer’s drug fails

By Ed Silverman

Prescription form

Pharmalot

There are fewer opioid prescriptions being written for Medicare Part D beneficiaries

By Ed Silverman

German pharmacy

Pharmalot

Germany belatedly finds that most new drugs did not offer meaningful benefits

By Ed Silverman

Biotech

Mass. Gov. Charlie Baker’s plan to curb drug prices strains his relationship with biotechs

By Priyanka Dayal McCluskey — Boston Globe

Pharmalot

Pharmalittle: Trump abandons rebate rule; biotechs fume at Mass. governor’s plan to lower drug prices

By Ed Silverman

Suboxone - Indivior demonstration dose

Pharmalot

Reckitt will pay $1.4 billion to settle federal probes into marketing of opioid-addiction treatment

By Ed Silverman

FDA campus

Pharmalot

FDA slams Akorn for a laundry list of manufacturing problems that put patients at risk

By Ed Silverman

Clinical Trials illo

Pharmalot

Pharma continues to get poor grades when it comes to sharing clinical trial data

By Ed Silverman

Pharmalot

Pharmalittle: White House edges near drug deal with Capitol Hill; U.K. offers plan for antibiotic development

By Ed Silverman

Pharmalot

A Supreme Court ruling may have made it harder to get some info from the FDA

By Ed Silverman

Pharmalot

Do doctors prescribe more Lyrica and similar painkillers because they receive pharma money?

By Ed Silverman

Pharmalot

Pharmalittle: Judge blocks Trump plan to run drug prices in TV ads; former Insys execs cooperate with the feds

By Ed Silverman

Pharmalot

Pharmalittle: Trump plans drug-pricing order; U.S. seeks extradition of Chinese researcher over trade secrets

By Ed Silverman